Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular glucose metabolism refers to the collection of biochemical pathways by which cells process and utilize glucose for energy production and biosynthetic needs. This includes glycolysis in the cytosol, conversion of pyruvate via the tricarboxylic acid cycle in mitochondria under aerobic conditions, oxidative phosphorylation for ATP generation on mitochondrial membranes, as well as ancillary processes like glycogenesis/glycogenolysis for storage/mobilization and the pentose phosphate pathway for nucleotide synthesis[1][3]. The regulation of these pathways is tightly controlled by hormones such as insulin and glucagon through modulation of key enzymes and transporters[2]. While many drugs target specific proteins within these pathways—such as SGLT2 inhibitors affecting renal reabsorption or metformin modulating hepatic gluconeogenesis—the term "intracellular glucose metabolism" does not refer to a single molecular entity but rather an integrated network essential for cell survival. Therefore, it is not considered a therapeutic target per se but encompasses multiple validated drug targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular glucose metabolism.